UpToDate: “Patient education: Deep vein thrombosis (DVT) (Beyond the Basics),” “Patient education: Pulmonary embolism (Beyond the Basics).”
CDC: “Venous Thromboembolism (Blood Clots): Diagnosis and Treatment,” “Venous Thromboembolism (Blood Clots): What Is VTE?”
National Heart, Lung, and Blood Institute: “Venous Thromboembolism,” “Lung VQ Scan.”
Society for Vascular Surgery: “Pulmonary Embolism.”
American Lung Association: “Learn About Pulmonary Embolism.”
MedlinePlus: “D-Dimer Test,” “Critical Care.”
UCSF Health: “Pulmonary Angiography.”
Harvard Medical School: “Ventilation-Perfusion Scan or V-Q Scan.”
Johns Hopkins: “Hematology.”
Cleveland Clinic: “Deep Vein Thrombosis (DVT): Diagnosis and Tests,” “Deep Vein Thrombosis (DVT): Management and Treatment.”
Mayo Clinic: “Deep vein thrombosis (DVT),” “MRI,” “CT Scan.”
American Academy of Family Physicians: “What is deep vein thrombosis (DVT)?”
National Blood Clot Alliance (NBCA): “Find a Healthcare Provider.”
National Institutes of Health: “How to Spot and Prevent Deep Vein Thrombosis.”
North American Thrombosis Forum: “Visiting the Emergency Department for a Blood Clot: What to Expect.”
UW Medicine: “Treating Blood Clots.”
Jefferson Health: “Deep Vein Thrombosis (DVT).”
The American Journal Of Managed Care : “Venous Thromboembolism: Role Of Pharmacists And Managed Care Considerations.”
Chest : “Accuracy of ultrasonography performed by critical care physicians for the diagnosis of DVT.”
Indiana Hemophilia & Thrombosis Center: “FAQs: Clotting Disorder Treatment at the IHTC.”
Tri-City Cardiology: “Deep Vein Thrombosis (DVT) Overview.”
Society for Vascular Surgery: “What is a Vascular Surgeon?” “Why do you need to see a vascular surgeon?”
Society for Cardiovascular Angiography and Interventions: “Treating Deep Vein Thrombosis with Angioplasty and Stenting.”
American College of Cardiology Foundation: “Acute Pulmonary Embolism: The Case for a Successful Comprehensive Treatment Program.”
You wear a cuff to measure not only your blood pressure but also the stiffness of your arteries, among other vascular readings, from home. You conduct your own vision tests for eyeglasses without leaving the house. You pee in your own toilet to capture urine samples you share remotely with your doctor.
Telehealth has brought doctors back into the house virtually via smartphone, computer and tablet screens. Now several health tests that used to require a trip to a doctor’s office or lab are also being done from the comfort of home. Others are on the cusp of being approved.
You can buy some tests off the shelf at your local pharmacy. Others may require a prescription from your physician, who can then monitor certain conditions from afar.
Health-related tests of one kind or another aren’t entirely new, of course. Women have been able to take home pregnancy tests for decades. Diabetics can prick their finger with a needle to test glucose levels or wear a continuous glucose monitor. Some people share their DNA through 23andMe to screen for hereditary conditions.
Millions have grown accustomed to home diagnostics by sticking a swab up their noses, however unpleasant, to test for COVID-19.
“The pandemic definitely changed a lot of people’s opinions of testing at home,” says virologist Mary Rodgers, principal scientist for diagnostics at Abbott, the North Chicago–based health care company behind the BinaxNOW-branded COVID tests.
Nearly half of adults ages 50 to 80 surveyed in July 2022 as part of the University of Michigan’s National Poll on Healthy Aging have purchased at least one at-home medical test. More than 4 in 5 expressed an interest in using them in the future.
“The people who tend to need these sorts of tests more are probably older people. But I think a lot of this is going to be driven by younger people, [who have] an expectation of convenience probably in a way that we never did,” says David Pride, M.D., professor of pathology and the director of microbiology at UC San Diego.
The latest generation of home tests may combine sophisticated sensors and artificial intelligence (AI) analysis, often in sync with a smartphone or smartwatch. These digital health tests cover a wide swath of concerns, as you can see from the following products, many of which were exhibited at the January 2023 CES tech fest in Las Vegas.
• Monitoring urine. Withings has launched U-Scan, which the French company markets as the world’s first at-home, hands-free urine lab. To use it, you urinate onto a pebble-shaped, 3½-inch-diameter rechargeable reader that sits in your toilet bowl.
U-Scan has interchangeable cartridges that can analyze various biomarkers. Among the first are a cartridge to help women track hormonal fluctuations in their cycles, and another that measures nutritional balance around vitamin C, ketones and hydration. Data syncs up via Wi-Fi with a smartphone app. Low-energy radar sensors embedded within the U-Scan reader help it identify your urine as distinct from, say, a family member’s.
U-Scan is slated to go on sale in Europe for €500 (about $535) around midyear but hasn’t yet received regulatory approval from the U.S. Food and Drug Administration.
Healthy.io’s Minuteful Kidney test also uses urine to uncover increased risk for chronic kidney disease in its early stages and avert damage that can lead to a kidney transplant or dialysis. The Tel Aviv–based company received FDA clearance last year for its home test kit, which uses a smartphone app to deliver immediate results.
• Identifying respiratory viruses. Opteev Technologies in Baltimore has developed a battery-powered, multiple-use handheld breath analyzer test called ViraWarn that the company says can detect all COVID variants, as well as respiratory syncytial virus (RSV) and influenza, in less than 60 seconds.
You blow into this electronic device twice. A carbon filter captures larger particles in your breath. Virus particles pass through. A flashing red light signifies a positive result, though the test won’t tell you what you have; a green light indicates a negative.
ViraWarn comes with a removable mouthpiece and replaceable sensor cartridges. It is in clinical trials and will require FDA approval.
• Checking arteries. The Pulse monitor from Conneqt in Newport Beach, California, promises to do more than the typical cuff-based blood pressure machine. It can capture a patient’s central pulse pressure, which is used to identify damage to the brain, heart and kidneys. Among other features, it can also measure augmentation pressure, a marker that indicates how stiff a person’s arteries are.
A vascular ring is a heart problem present at birth. That means it's a congenital heart defect. In this condition, part of the body's main artery or its branches form a ring around the windpipe, the food swallowing tube or both.
A vascular ring may be complete or incomplete.
Surgery is usually needed to treat a vascular ring.
Some people with a vascular ring don't have symptoms. Sometimes symptoms aren't noticed until later in life. If a vascular ring presses against the trachea and esophagus, it can lead to breathing and digestive problems.
Symptoms of a vascular ring may include:
Some people born with a vascular ring also may have other heart problems at birth. Specific symptoms depend on the type of heart problems present.
A health care provider does a physical exam and asks questions about the symptoms. Tests done to diagnose a vascular ring may include:
Imaging tests. A chest X-ray can show changes in the windpipe that might suggest a vascular ring. The test also can show which side of the body the aortic arch is on.
Other imaging tests may include an echocardiogram, a CT angiogram or an MRI scan. Health care providers also may use these tests to plan treatment.
Surgery is usually done to treat a vascular ring that presses against the trachea or esophagus. Surgery also helps prevent complications.
During surgery, the health care provider splits the vascular ring to stop the blood vessel from pressing against the windpipe and food pipe. The surgery may be done as open-heart surgery or as a minimally invasive approach.
The specific type of surgery depends on the type of heart problems present.
People born with a vascular ring need regular health checkups for life to prevent complications.
©2023 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.
usatoday.com cannot provide a good user experience to your browser. To use this site and continue to benefit from our journalism and site features, please upgrade to the latest version of Chrome, Edge, Firefox or Safari.
The MarketWatch News Department was not involved in the creation of this content.
Feb 18, 2023 (The Expresswire) -- [144 Insights] Top “Vascular Stents Market” Size 2023 Key players Profiled in the Report are [, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik Se and Co. Kg, B. Braun Melsungen Ag, Terumo Corporation, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts Limited, C.R. Bard, Inc., W.L. Gore and Associates, Inc., Endologix, Inc., Lombard Medical, Translumina Gmbh, Jotec Gmbh,] most important, influential, or successful companies, brands, or individuals within a Vascular Stents market 2023 to 2026.
Complete Overview of the Global Vascular Stents Market: -Providing a complete overview of the global Vascular Stents market is a complex task, as there are many different markets and industries around the world. However, I can provide a high-level summary of some of the key trends and factors that are currently impacting the global Vascular Stents market. Economic Growth, Technology, E-commerce, Globalization, Sustainability, Demographics, Political and regulatory risks These are just a few of the many factors that are currently shaping the global market. It is a dynamic and ever-changing environment, and businesses that are able to adapt to new trends and challenges are likely to be the most successful.
Vascular Stents Market Provides High-class Data: - It is true that the global Vascular Stents market provides a wealth of high-quality data for businesses and investors to analyse and make informed decisions. There are many different sources of market data, including government statistics, industry reports, financial news, and market research firms. Some of the key types of data that are available from the global Vascular Stents market include, Economic data, Financial data, Industry data, Consumer data However, it is important to carefully evaluate the quality and reliability of data sources and to use multiple sources of data to gain a more complete understanding of the Vascular Stents market.
Get a sample Copy of the Vascular Stents Report 2023
Top Country Data and Analysis: - for United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Vascular Stents Markets such as North America, Europe, Asia-Pacific, South America and Middle East and Africa
Description and Analysis of Vascular Stents market: - Vascular Stents Market analysis is the process of evaluating market conditions and trends in order to make informed business decisions. A market can refer to a specific geographic location, particular industry or sector, develop strategies for entering or expanding in a particular Vascular Stents market.
Vascular Stents Market analysis can also involve forecasting future market trends and conditions, based on factors like technological change, regulatory developments, or demographic shifts. This can be used to develop long-term strategic plans and to identify potential risks and opportunities for growth.
Overall, market analysis is an important tool for businesses looking to enter or expand in a particular Vascular Stents market. By carefully evaluating Vascular Stents market conditions and trends, businesses can make more informed decisions and develop strategies that are better aligned with customer needs and Vascular Stents market opportunities.
Get a sample Copy of the Report at
Market Analysis and Insights: Global and United States Vascular Stents Market
This report focuses on global and United States Vascular Stents Global and United States market.
The global Vascular Stents market size is projected to reach USD million by 2026, from USD million in 2020, at a High CAGR of during 2021-2026.
Global Vascular Stents Scope and Market Size
Vascular Stents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Vascular Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.360marketupdates.com/enquiry/pre-order-enquiry/16393847
Market segment by Region/Country including: -● North America (United States, Canada, and Mexico) ● Europe (Germany, UK, France, Italy, Russia and Spain, etc.) ● Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.) ● South America (Brazil, Argentina, Colombia, etc.) ● Middle East and Africa (South Africa, UAE, Saudi Arabia, etc.)
User center of Vascular Stents market 2023
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and we elaborate at full length on the impact of the pandemic and the war on the Precious Metals Industry.
Final Report will add the analysis of the impact of COVID-19 on this industry.
TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT - REQUEST SAMPLE
The Global Vascular Stents market is anticipated to rise at a considerable rate during the forecast period. the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Vascular Stents Market -SegmentationAnalysis:
Report further studies the market development status and future Vascular Stents Market trend across the world. Also, it splits Vascular Stents market Segmentation by Type and by Applications to fully and deeply research and reveal market profile and prospects.
Segment by Type● Bare-metal Stents ● Drug-eluting Stents ● Bioabsorbable Stents ●
Which growth factors drives the Vascular Stents market growth?
Increasing use of is expected to drive the growth of the Vascular Stents Market.
Segment by Application● Hospitals and Cardiac Centers ● Ambulatory Surgical Centers ●
Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
It also provides accurate information and cutting-edge analysis that is necessary to formulate an ideal business plan, and to define the right path for rapid growth for all involved industry players. With this information, stakeholders will be more capable of developing new strategies, which focus on market opportunities that will benefit them, making their business endeavors profitable in the process.
Get a sample PDF of report https://www.360marketupdates.com/enquiry/request-sample/16393847
Vascular Stents Market - Competitive Analysis:
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
Vascular Stents Industry leading players are the ones that have the biggest impact, the most market shares 2023, the best reputation, or the highest revenue within their field they are
Who are the Leading Players in Vascular Stents Market?● Medtronic Plc ● Abbott Laboratories ● Boston Scientific Corporation ● Biotronik Se and Co. Kg ● B. Braun Melsungen Ag ● Terumo Corporation ● Microport Scientific Corporation ● Meril Life Sciences Pvt. Ltd. ● Vascular Concepts Limited ● C.R. Bard, Inc. ● W.L. Gore and Associates, Inc. ● Endologix, Inc. ● Lombard Medical ● Translumina Gmbh ● Jotec Gmbh ●
Get a sample Copy of the Report at
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters:
1.To study and analyze the global Vascular Stents consumption (value) by key regions/countries, product type and application
2.To understand the structure of Vascular Stents Market by identifying its various sub segments.
3.Focuses on the key global Vascular Stents manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Vascular Stents with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Vascular Stents submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Get a sample Copy of the Report at https://www.360marketupdates.com/enquiry/request-sample/16393847
Major Points from Table of Contents
1 Market Overview
1.1 Vascular Stents Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.5 Market Dynamics
2 Manufacturers Profiles
3 Global Vascular Stents Market Competition, by Manufacturer
4 Global Vascular Stents Market Analysis by Regions
5 North America Vascular Stents by Countries
6 Europe Vascular Stents by Countries
7 Asia-Pacific Vascular Stents by Countries
8 Latin America, Middle and Africa Vascular Stents by Countries
9 Vascular Stents Market Segment by Type
10 Vascular Stents Market Segment by Application
11 Vascular Stents Market Forecast (2016-2021)
12 Sales Channel, Distributors, Traders and Dealers
13.2 Data Source
Key Reasons to Purchase● To gain insightful analyses of the market and have comprehensive understanding of the global Vascular Stents Market and its commercial landscape. ● Assess the production processes, major issues, and solutions to mitigate the development risk. ● To understand the most affecting driving and restraining forces in the Vascular Stents Market and its impact in the global market. ● Learn about the Vascular Stents Market strategies that are being adopted by leading respective organizations. ● To understand the future outlook and prospects for the Vascular Stents Market. ● Besides the standard structure reports, we also provide custom research according to specific requirements
Purchase this Report (Price 3900 USD for a Single-User License) https://www.360marketupdates.com/purchase/16393847
360 Market Updates
Phone : US +1 424 253 0946
UK +44 203 239 8187
Web:https://www.360marketupdates.comFor More Related Reports Click Here :
Cosmetic Antioxidants Market Is Booming With Great Opportunities and Growing With Important Updates
Unstructured Data Solution Market 2023 [Newest 102 Pages Report] is Booming Worldwide 2029
Data Center Backup and Recovery Solutions Industry Research Report, Competitive Landscape, Market: What Strategies Do Companies to Increase Industry Share and Revenue Source?
Multi-factor Authentication Technology Market [New Research Report of 117+ Pages] Gives Up to Date Analysis of Industry 2029
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Vascular Stents Market by Manufacturers like Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik Se & Co. Kg
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
Vascular dementia is a general term describing problems with reasoning, planning, judgment, memory and other thought processes caused by brain damage from impaired blood flow to your brain.
There's no specific test that can confirm vascular dementia. Instead, health care professionals make a judgment based on any medical history for stroke or disorders of the heart and blood vessels, and results of tests that can clarify the diagnosis.
Vascular dementia symptoms vary, depending on the part of your brain where blood flow is impaired. Symptoms often overlap with those of other types of dementia, especially Alzheimer's disease. But unlike Alzheimer's disease, the most significant symptoms of vascular dementia tend to involve speed of thinking and problem-solving rather than memory loss.
Vascular dementia signs and symptoms include:
Vascular dementia results from conditions that damage your brain's blood vessels, reducing their ability to supply your brain with the amounts of nutrition and oxygen it needs to perform thought processes effectively.
Common conditions that may lead to vascular dementia include:
In general, the risk factors for vascular dementia are the same as those for heart disease and stroke.
Risk factors for vascular dementia include:
Treatment often focuses on managing the health conditions and risk factors that contribute to vascular dementia. Controlling conditions that affect the underlying health of your heart and blood vessels can slow the rate at which vascular dementia worsens and prevent further decline.
Depending on your individual situation, your health care professional may prescribe medications to:
The health of your brain's blood vessels is closely linked to your overall heart health. Taking these steps to keep your heart healthy also can reduce your risk of vascular dementia:
Citation: What is vascular dementia? (2023, February 2) retrieved 19 February 2023 from https://medicalxpress.com/news/2023-02-vascular-dementia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction. The first synthetic vascular grafts (blood vessel replacements) were developed just after World War II and were fabricated from materials such as parachute cloth, stitched on home sewing machines. By the 1970s, commercial vascular grafts were introduced, made primarily from Dacron fabric or expanded Teflon (ePTFE).
These larger diameter (>5mm) grafts work satisfactorily for replacing or repairing large blood vessels. However, there are many needs where small diameter vascular grafts (SDVG) would be beneficial. For example, there are about 1 million leg amputations worldwide, mostly due to clogged blood vessels.
Synthetic blood vessel grafts in small sizes most often fail in this demanding, low-flow anatomical site. Also, surgeons would be pleased to have synthetic grafts suitable for heart bypass surgery, but no SDVG will work in this site. The FDA has never approved vascular grafts with diameters smaller than 5 mm. Why after 70+ years have vascular grafts not advanced in performance? There have been almost 50,000 technical papers published on vascular grafts, many proposing novel designs and novel biomaterials. So, research is ongoing—yet there is no cohesive theory to drive SDVG development.
In a perspective article published in the journal BME Frontiers, a new hypothesis is formulated that may reveal a path to the desired SDVG. After reviewing historical precedents and the pros and cons of many vascular graft approaches, the article proposes that we must emulate the structure and behavior of the natural, living artery.
Key elements of a next generation SDVG will be a living, functioning endothelial cell lining, a blood vessel network within the walls of the graft (a "pseudo vasa vasorum") and biomechanics to match the elasticity of the natural artery being replaced. Importantly, the graft cannot trigger the foreign body reaction (FBR) that leads to a fibrotic scar capsule with low vascularity and activated macrophages.
Most of our accepted biomaterials today (Teflon, Dacron, for example) trigger this FBR. The FBR reaction, if mild, is accepted by medical device regulatory agencies. However, the case is made that the FBR is really a manifestation of chronic inflammation—an ongoing, unending attack against the biomaterial.
The biomaterial essentially never truly heals in the body. Thus, so-called biocompatible biomaterials are perhaps not so biocompatible! This ongoing inflammation inhibits the formation of a healthy endothelial cell layer and the rigid foreign body capsule prevents the normal flexing pulsation of an implanted graft. Grafts showing the FBR are poised to fail because they do not have a healthy, living endothelial lining and their non-flexing walls and capsule contracture reduce blood flow and produce flow disturbances which lead to thrombosis.
Fortunately, there are new biomaterials being developed that inhibit the FBR and show reconstructive, regenerative healing. The central hypothesis of the paper suggests that these types of new materials can lead to successful vascular grafts that more closely emulate the performance of the natural artery. A number of vascular graft approaches based upon engineering natural tissues show this regenerative healing and are being explored in the lab and clinic.
These have promise, but there is a concern about long-term durability due to the body's mechanisms to digest older tissue. Also, there are new biomaterials such as a porous structure with 40 micron interconnected pores that heals in a non-fibrotic, vascularized manner. These new vascular graft approaches offer the possibility of SDVG that heal in a reconstructive manner and function much like the natural vessel they are intended to replace.
More information: Buddy Ratner, Vascular Grafts: Technology Success/Technology Failure, BME Frontiers (2022). DOI: 10.34133/bmef.0003
Provided by BMEF (BME Frontiers)
Citation: Vascular grafts: Technology success or technology failure? (2023, January 30) retrieved 19 February 2023 from https://medicalxpress.com/news/2023-01-vascular-grafts-technology-success-failure.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- From celebrated vascular surgeon and veteran medical maverick Dr. Frank J. Veith comes a captivating memoir and exposé of the medical establishment that unveils an often clubby industry that many believe needs serious reform. the medical jungle: a pioneering surgeon's battle to revolutionize vascular care and challenge the medical mafia (Amplify Publishing; February 7) candidly recounts Dr. Veith's countless battles inside what he calls the 'medical jungle'--a cut-throat environment that threatens as much as it heals.continue reading
Renowned Vascular Surgeon Unveils Dark Side of the Medical Profession in Revealing New Memoirtweet this
Part captivating memoir, part disclosure of a self-serving system, The Medical Jungle recounts Dr. Veith's tireless efforts to Improve medical care for patients. With wisdom garnered from a sixty-year career as a pioneering surgeon, Dr. Veith pulls back the curtain on the inner workings of innovative medical procedures, while candidly describing the self-interested parties that sought to block progress with no thought to how their actions would impact patient care.
The New York Times calls Dr. Veith 'an unlikely radical...waging an aggressive fight in the clubby world of the medical profession' for his tireless advocacy of patients and medical progress instead of the hospital's bottom line-no matter the consequences. The Medical Jungle will inspire anyone who faces adversity at any level to stand up and be radical, even when it is unpopular.
A starred review from
blue ink review
calls The Medical Jungle 'a fascinating chronicle of the complex inner workings of the 'medical jungle,'' while
kirkus calls the book 'an engaging and evocative medical memoir.' Former president of the European Society of Vascular Surgery Sir Peter R. F. Bell calls it 'a must read for doctors and the public.'
Frank J. Veith, MD, is one of America's leading vascular surgeons, a pioneering creator of life- and limb-saving medical advances, and the chairman of VEITHsymposium-the largest vascular surgery conference in the world. He currently serves as a professor of surgery at NYU and the Cleveland Clinic and was honored with the Lifetime Achievement Award from the Society of Vascular Surgery. Glenn Plaskin is the bestselling author of twenty-five books and his profiles and syndicated columns have appeared in the New York Times, the Daily News, Los Angeles Times, Chicago Tribune, Cosmopolitan, W, and Playboy.
Dr. Frank Veith is available for interviews, features, and events, and The Medical Jungle is on sale now through amazon , barnes & noble , and
amplify publishing . To learn more about Dr. Veith visit medicaljunglebook.com .
SOURCE Amplify Publishing
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
If you’re confounded by the constant and seemingly contradictory studies proclaiming that caffeine is either a benefit or a bust for your heart, you’re not alone.
But while medical professionals acknowledge that drawing conclusions can be difficult, they urge consumers to take the dueling research with a grain of salt (or sugar) and use common sense with their coffee intake.
“There’s a lot of confusion and uncertainty out there,” said Dr. Will Baker, a cardiologist with UCHealth Heart and Vascular Clinics in Steamboat Springs and Craig. “While the evidence is mixed, in general, there is no strong evidence that caffeine is bad for you. It’s probably fine, and possibly even beneficial, if you limit it to about one or a few cups per day.”
The problem with studies that tout the advantages of eating or drinking certain foods is that they are observational in nature and draw conclusions from surveying the habits of large groups of people over a certain length of time, he said. A myriad of variables could alter the results.
A more valid approach would include two test groups – one that drank coffee and one that drank a placebo that tasted like coffee. After a certain length of time, researchers could study the link between various health-related issues and caffeine. These types of studies are limited regarding coffee.
“Lacking a study like that, it’s pretty hard to sort out a true cause and effect,” Baker said.
Not all coffee is created equal
Most of the studies that have been reported are limited to filtered coffee. Unfiltered coffee like espresso, French press or boiled ground-type coffee may be a different story.
Unfiltered coffee has higher levels of chemicals including cholesterol-raising diterpenes. These chemical compounds are diluted in filtered coffee since it goes through a paper filter, and they can increase the level of LDL cholesterol, also known as “bad cholesterol.” LDL cholesterol levels are associated with a higher risk for heart attacks and strokes.
In addition to different types of coffee, people will react to coffee and presumably caffeine differently, depending upon their body’s metabolism. Baker wants people to pay attention to their caffeine intake and its effects on their mood, sleep habits, body rhythms, alertness and overall feeling of wellness. It is also possible that other substances in coffee may be beneficial, such as antioxidants.
“There’s a lot of individual variability in how people will respond,” Baker said. “There’s also a degree of tolerance as people habituate to the effects of caffeine over time, so how much coffee you consume regularly can affect your response.”
Baker said patients arrive at his office after suffering a heart attack or experiencing heart irregularities like atrial fibrillation, which is a type of heart arrhythmia where the heart beats irregularly or too fast or too slow, and announce they are cutting caffeine cold turkey.
For some, it might make a difference. For others, it won’t.
“Some will go ahead and stop drinking coffee and their heart palpitations go away,” said Baker. “For others, cutting out caffeine doesn’t make a difference, so again, people respond in different ways.”
A bigger worry to him than a cup or two of joe for his patients are other selections available at a coffee shop or in a grocery store aisle.
Beverages such as caffeinated energy drinks, soft drinks and even some teas can contain up to five times as much caffeine as coffee. And then there are calorie-laded “coffee” options with a little caffeine and a host of dairy products and sugar that can pack as many calories as a milkshake.
“These energy drinks are often loaded with large amounts of caffeine or other stimulants, while some of the coffee drinks are laden with sugar and other substances with little or no nutritional value,” he said.
Baker said some of the best advice he dispenses comes back to what your mother and grandma may have extolled: Don’t do anything to excess.
“I’ve never told anyone to stop drinking coffee,” he said. “So go ahead and enjoy your caffeine, but like anything, just do it in moderation, and pay attention to how it affects you.”
An esteemed surgeon has launched a new private vascular health clinic.
L&P Vascular will be based in Rossett, between Wrexham and Chester, and offer consultation and surgical procedures for people with conditions that affect the arteries, veins, and the lymphatic system, including varicose veins.
With more than 30 years’ experience in the UK and Hungarian health services, director Laszlo Papp is a well-known name in the sector having obtained the European Qualification in Vascular Surgery (FEBVS) two decades ago.
He is also one of only 12 Professors of Vascular Surgery in Europe to hold a Gold Examiner award from the FEBVS (Fellow of the European Board for Vascular Surgery) and was a visiting professor at Yale University in the US.
Laszlo said the practice will complement existing NHS services and offer people the chance to avoid lengthy waiting times given that more than 400 people in North Wales alone are on the list to be treated for varicose veins.
“Our main focus will be consultation and treatment of varicose veins, but we are also able to support people with a range of conditions affecting the arteries and lymphatic system,” he said.
“The waiting times can be quite lengthy for these issues – often several years, depending on how serious it is – but we would expect to be able to see people within a matter of weeks or months.
“There is a huge demand for this service so it’s an interesting and exceptionally busy time to begin this next chapter in my professional life.”
L&P Vascular is a private practice that will be sited at the award-winning Pure Perfection Clinic on Chester Road.
Featuring innovative medical technology and ultrasound scanning equipment, it will use a variety of procedures and methods to treat varicose veins – swollen and enlarged veins which tend to appear on the legs and feet, often twisted and bulging, causing pain and discomfort and even ulceration of the leg.
However, with research revealing more than 30% of the UK will develop varicose veins in their lifetime – and women are more likely to do so than men – people are urged to look out for other symptoms including itchy, sore skin over the veins, swollen legs, and hard tender lumps.
Laszlo revealed in the majority of cases keyhole surgery takes 40 minutes if one leg is treated to 1.5-2 hours if a more extensive treatment is needed or two legs are treated on the same occasion. The majority of patients will be able to walk in and walk out after a short period of rest and recovery.
Other services he will provide include Doppler tests for arterial disease, radiofrequency ablation treatment, and foam sclerotherapy and injection sclerotherapy of varicose veins.
“If varicose veins are causing long-term complications that could lead to a blood clot or leg ulcer. Offering our services means the patient will not have to wait as long for treatment as they would have via their local health board,” he said.
“But in most cases the issue is cosmetic or causing minor discomfort, so the wait is years rather than months.”
“To be able to open the clinic in such a perfect location is a great thrill for me; we have already had a lot of interest from not only North Wales but Cheshire, Wirral and into the North West so it’s an exciting time.”
Sara Cheeney, Director of Pure Perfection Clinic, added:
“We are delighted for Laszlo and for L&P Vascular to be based here, offering private clients another high-quality, much-needed medical service in this region.”
For more information, call 01244 917259 or email [email protected].